1. Home
  2. THRY vs FATE Comparison

THRY vs FATE Comparison

Compare THRY & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$3.18

Market Cap

114.8M

Sector

Industrials

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.35

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRY
FATE
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.8M
125.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
THRY
FATE
Price
$3.18
$1.35
Analyst Decision
Buy
Buy
Analyst Count
4
6
Target Price
$9.33
$4.10
AVG Volume (30 Days)
502.2K
1.2M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
100.50
29.88
EPS
0.01
N/A
Revenue
$785,015,000.00
$6,646,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$339.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$0.91
52 Week High
$15.49
$1.94

Technical Indicators

Market Signals
Indicator
THRY
FATE
Relative Strength Index (RSI) 50.76 55.22
Support Level $2.46 $0.95
Resistance Level $3.69 $1.45
Average True Range (ATR) 0.21 0.09
MACD 0.06 0.01
Stochastic Oscillator 49.70 65.63

Price Performance

Historical Comparison
THRY
FATE

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: